The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA Peptide Reclassification 2026: What It Means for Providers BPC 157: Miracle Healing Peptide or Hidden Danger?